Luminor DCB, now in Japan
Barcelona, Spain – iVascular and Medico’s Hirata announce that Luminor Drug Coated Balloon (DCB) has received approval from Japan’s Ministry of Health, Labour and Welfare...
Exceptional Long-Term Outcomes of iVascular Angiolite Drug-Eluting Stent in Real-Life Clinical Practice
Barcelona— iVascular is pleased to announce the positive 5-year results of the RANGO registry, which provide strong evidence of the long-term safety and efficacy of...
iVascular initiates OPAL study with its new embolic liquid Amber
iVascular announces the initiation of Opal, the first human study with the new embolic liquid Amber, based on a radiopaque biocompatible copolymer. OPAL is a...
Exceptional Navigability of iVascular essential pro drug-coated balloon for the treatment of coronary in-stent restenosis
Barcelona, June 19, 2024 — iVascular is pleased to announce the publication of positive results from a prospective single-center study, demonstrating that the company’s essential...
The first results of the SOL Japan Study highlight the excellent efficacy of Luminor DCB in the Japanese population
iVascular is pleased to announce the outstanding results of the SOL Japan study, recently presented at the JET (Japan Endovascular Treatment)Conference. SOL Japan is a...
Research Chair in Surgery at the UAB Faculty of Medicine
We are thrilled to announce the establishment of the Research Chair in Surgery at the UAB Faculty of Medicine, thanks to our most recent collaboration...
iVascular announces first enrollment in new ANGIODAPT trial, an RCT of abbreviated DAPT post-stent implantation in all-comers
First patient enrolled in ANGIODAPT Trial, an RCT of abbreviated DAPT post-stent implantation with Angiolite DES. iVascular has announced the initiation of its first randomized...
LUMIFOLLOW preliminary 1 year outcomes revealed at PVI 2023
Luminor DCB has confirmed its excellent safety and efficacy in femoropopliteal lesions with new study LUMIFOLLOWiVascular presented at PVI (Paris Vascular Insights) the 1 year...
BIBLIOS STUDY FULL COHORT RESULTS on BTK lesions presented at PVI
iVascular presented Luminor DCB in BTK outcomes obtained in the BIBLIOS trial 1-year follow-up at PVI 2023 (Paris Vascular Insight). BIBLIOS is a prospective, single-arm,...
BIBLIOS study first results on BTK lesions presented at linc
iVascular presented for the first time Luminor in BTK outcomes obtained in the BIBLIOS trial at LINC 2022 (Leipzig Interventional Course) and its first preliminary...
iVascular announces first patients enrolled in BARISTA clinical trial
iVascular recently announced the first patient enrollments in the BARISTA study, a Belgian physician-initiated study to assess the efficacy and safety of the Restorer balloon...
RANGO Registry new 3-year follow up outcomes
After the positive pre-clinical and clinical results with Angiolite, the cobalt-chromium sirolimus-eluting stent of iVascular, the company decided to further assess Angiolite performance in a...
iVascular announces first enrollment in iliCo study with iCover
iVascular has announced the initiation of its first trial with the new generation covered stent iCover: the iliCo Study. iliCo has the objective of evaluating...
iVascular covered stent iCover, has received CE mark.
Barcelona, 04th of May 2021. iVascular has recently received CE mark approval for its BX covered stent iCover. Balloon-expanding (BX) covered stents are commonly used...
iVascular Initiates Trial of Luminor DCB in Japan
Barcelona, 15th of April 2021. We are pleased to announce the commencement of recruitment of Luminor’s first study in Japan (SOL-JAPAN Trial) together with Medicos...
iVascular launches LUMIFOLLOW trial in Europe for the treatment of femoropopliteal lesions with Luminor DCB
iVascular today announced that the recruitment of the prospective, multicenter, consecutive, post-market LUMIFOLLOW trial has begun. This trial was created with the aim of evaluating...
iVascular, Angiolite DES offers new long lengths of 44 and 49mm.
Barcelona, February 9th, 2021. We are pleased to announce the launch of Angiolite DES new long lengths, for the treatment of long lesions. The 44...
iVascular – New BTK evidence with Luminor DCB: MERLION Trial 1 year follow-up
Barcelona, February 4th, 2021. New Luminor DCB evidence in complex BTK lesions has been presented on the main session of LINC 2021, the interventional course...
Barcelona February 4th, 2021.…
Barcelona February 4th, 2021. New Luminor DCB clinical evidence in complex lesions and long term follow up, has been presented on the main session of...
iVascular, Angiolite 6.00 mm maximum overexpansion capacity.
We are pleased to announce that Angiolite DES, offers one of the highest overexpansion capacities for medium and large vessels. This excellent feature helps to...
No news found matching these filters.
Contacta con nosotros
Ponemos a tu disposición varios canales de contacto para atender todas tus consultas.
